We evaluate the clinical effects of different strategies for preventing coronary microvascular obstruction.
The strategies include intracoronary injection of a Glycoprotein (GP) IIb/IIIa inhibitors and installation of a distal protective device, in STEMI patients with a high thrombus-burden plaque.
We explore the eradication for post-MI angina if we perform these strategies to prevent coronary microvascular obstruction.
We provide different strategies for prevention of coronary microvascular obstruction and the eradication for post-MI angina.